Technological achievements in radiotherapy of malignant brain tumors
pdf (Русский)

Keywords

brain metastases
technological achievements of radiotherapy

How to Cite

Panshin Georgy , G. (2022). Technological achievements in radiotherapy of malignant brain tumors . Voprosy Onkologii, 68(4), 434–438. https://doi.org/10.37469/0507-3758-2022-68-4-434-438

Abstract

Today, radiotherapy plays a crucial role in the treatment of malignant brain tumors. At the same time, in general, recent advances in clinical oncology concerning modern methods of radiotherapeutic treatment of malignant neoplasms, in contrast to the already traditional 3D-conformal radiotherapy (3D-CRT), include its use with modulated intensity (IMRT), volume-modulated arc therapy (VMAT) and stereotactic radiosurgery (SRS). All these methods make it possible to deliver higher doses of radiation to the target volume, while at the same time reducing the risk of increased toxicity to normal tissues, compared to the already traditional 3D conformal radiotherapy (3D-CRT). Moreover, proton therapy can currently be an alternative to photon irradiation due to a more favorable dose distribution over the target volume.        In the presented first part of the general review concerning the problem of "Metastases of malignant tumors in the brain", a brief report is offered on the latest technological achievements in radiotherapy of malignant brain tumors and their clinical impact on the special treatment of this category of neuro-oncological patients.

https://doi.org/10.37469/0507-3758-2022-68-4-434-438
pdf (Русский)

References

Cho B. Intensity-modulated radiation therapy: a review with a physics perspective //Radiation oncology journal. 2018;36(1):1. DOI:10.3857/roj.2018.00122

Rong Y., Welsh J.S. Dosimetric and clinical review of helical tomotherapy //Expert review of anticancer therapy. 2011;11(2):309-320. DOI: 10.1586/era.10.175

Teoh M. et al. Volumetric modulated arc therapy: a review of current literature and clinical use in practice //The British journal of radiology. 2011;84(1007):967-996. DOI:10.1259/bjr/22373346

Georg D., Knöös T., McClean B. Current status and future perspective of flattening filter free photon beams //Medical physics. 2011;38(3):1280-1293. DOI:10.1118/1.3554643

Kazda T., Jancalek R., Pospisil P. et al. Why and How to Spare the Hippocampus during Brain Radiotherapy: The Developing Role of Hippocampal Avoidance in Cranial Radiotherapy. Radiotherapy & Oncology, 2014;9, 139(1):1-10. http://dx.doi.org/10.1186/1748-717X-9-139

Wagner, D., Christiansen, H., Wolff, H., Vorwerk, H. (2009) Radiotherapy of Malignant Gliomas: Comparison of Volumetric Single Arc Technique (RapidArc), Dynamic Intensity-Modulated Technique and 3D Conformal Technique. Radiother Oncol, 93, 593-596. DOI:10.1016/j.radonc.2009.10.002

Yi-Dong Chen, Jin Feng, Tong Fang et al. Effect of intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy on clinical outcomes in patients with glioblastoma multiforme //Chinese Medical Journal. 2013;126(12):2320-2324. DOI:10.3760/cma.j.issn.0366-6999.20130218

Chargari, C., Goodman, K. A., Diallo, I. et al. Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models? Cancer and Metastasis Reviews, 2016;35(2):277-288. DOI:10.1088/0031-9155/59/12/2883

Patil V.M., Kapoor R., Chakraborty S. et al. Dosimetric risk estimates of radiation-induced malignancies after intensity modulated radiotherapy. Journal of Cancer Research and Therapeutics, 2010;6(4):442. doi: 10.4103/0973-1482.77082.

Kondziolka D., Shin S. M., Brunswick A., Kim I., Silverman J.S. The biology of radiosurgery and its clinical applications for brain tumors. Neuro-oncology, 2015;17(1):29-44. DOI: 10.1093/neuonc/nou284

Schiller F., Fleckenstein J., Simeonova A., Wentz F. and Ent F. Intensity-modulated radiosurgery of brain metastases with flattening of rays without filters. Radiation Therapy and Oncology, 2013;109(3):448-451. DOI:10.1016/j.radonc.2013.10.017

Aoyama X , Latitude X , Tago M. et al. Stereotactic radiosurgery plus radiotherapy of the whole brain compared to stereotactic radiosurgery only for the treatment of brain metastases: a randomized controlled trial. JAMA. 295:2483-2491. DOI:10.1001/JAMA.295.21.2483.

Yamamoto, Masaaki, Serizawa, Toru Shuto et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol. 2014; 15:387-395. DOI:10.1016/S1470-2045(14)70061-0 .

Ruggero Ruggieri, Stefania Naccarato, Rosario Mazzola et al. 2Linac-based VMAT radiosurgery for multiple brain lesions: Comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique. Radiat Oncol. 2018;13:38. DOI:10.1186/s13014-018-0985-2.

Jaffray D.A. Image-guided radiotherapy: from current concept to future perspectives //Nature reviews Clinical oncology. 2012;9(12):688-699. doi: 10.1038/nrclinonc.2012.194.

Nam P Nguyen 1, Mai L Nguyen, Jacqueline Vock. Potential applications of imaging and image-guided radiotherapy for brain metastases and glioblastoma to improve patient quality of life. Frontiers in Oncology. 2013;3:284. DOI:10.3389/fonc.2013.00284 .

Yuh, G.E., Loredo, L.N., Yonemoto, L.T. et al. (2004). Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children. The Cancer Journal. 10(6):386-390. DOI:10.3109/0284186X.2014.887225

Yoon, M., Shin, D.H., Kim J. et al. Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy. International Journal of Radiation Oncology Biology Physics, 2011;81(3):637-646. https://doi.org/10.1016/j.ijrobp.2010.06.039 DOI:10.4236/ijmpcero.2013.21005

Barney, C.L., Brown, A.P., Grosshans, D.R. et al. Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation. Neuro-oncology, 2014;16(2):303-309 DOI:10.1093/neuonc/not155

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2022